Emerging therapies pose challenges for standardizing QC.
Theresa L. Whiteside
Advertisement
Articles by Theresa L. Whiteside
Advertisement
Latest Updated Articles
Evaluation of Dendritic Cell Products Generated for Human Therapy and Post-Treatment Immune MonitoringPublished: March 1st 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Ask the Expert: Commenting on Draft Regulations
2
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
3
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
